Casey Woodring
Stock Analyst at J.P. Morgan
(4.14)
# 1,604
Out of 4,703 analysts
195
Total ratings
65.6%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintained: Buy | $180 → $190 | $150.86 | +25.94% | 5 | Aug 27, 2026 | |
| QDEL QuidelOrtho | Maintained: Sell | $12 | $13.97 | -14.10% | 20 | Aug 24, 2026 | |
| QGEN Qiagen | Maintained: Buy | $50 | $43.47 | +15.02% | 20 | Aug 10, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $38 → $50 | $62.65 | -20.19% | 5 | Aug 10, 2026 | |
| SHC Sotera Health Company | Maintained: Hold | $16 → $18 | $18.90 | -4.76% | 15 | Aug 10, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $32 → $35 | $30.80 | +13.64% | 3 | Aug 10, 2026 | |
| NTRA Natera | Reiterated: Buy | $315 → $360 | $328.18 | +9.70% | 6 | Aug 7, 2026 | |
| BRKR Bruker | Maintained: Buy | $65 → $60 | $58.50 | +2.56% | 4 | Aug 6, 2026 | |
| RVTY Revvity | Maintained: Hold | $90 → $110 | $130.22 | -15.53% | 4 | Aug 6, 2026 | |
| WAT Waters | Maintained: Hold | $370 → $400 | $409.38 | -2.29% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $25 | $25.07 | -0.28% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $130 | $99.39 | +30.80% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $160 → $310 | $288.50 | +7.45% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $155 → $165 | $164.85 | +0.09% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $218.22 | +5.40% | 8 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,200 → $1,400 | $1,345.26 | +4.07% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 | $161.41 | +20.81% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $45 | $64.62 | -30.36% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $14.97 | -19.84% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $175 | $167.60 | +4.42% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $255 → $285 | $267.77 | +6.43% | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $690 | $613.78 | +12.42% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $220 | $207.66 | +5.94% | 8 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $3.48 | n/a | 5 | Aug 9, 2024 |
Agilent Technologies
Aug 27, 2026
Maintained: Buy
Price Target: $180 → $190
Current: $150.86
Upside: +25.94%
QuidelOrtho
Aug 24, 2026
Maintained: Sell
Price Target: $12
Current: $13.97
Upside: -14.10%
Qiagen
Aug 10, 2026
Maintained: Buy
Price Target: $50
Current: $43.47
Upside: +15.02%
10x Genomics
Aug 10, 2026
Maintained: Hold
Price Target: $38 → $50
Current: $62.65
Upside: -20.19%
Sotera Health Company
Aug 10, 2026
Maintained: Hold
Price Target: $16 → $18
Current: $18.90
Upside: -4.76%
Alamar Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $30.80
Upside: +13.64%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $315 → $360
Current: $328.18
Upside: +9.70%
Bruker
Aug 6, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $58.50
Upside: +2.56%
Revvity
Aug 6, 2026
Maintained: Hold
Price Target: $90 → $110
Current: $130.22
Upside: -15.53%
Waters
Aug 6, 2026
Maintained: Hold
Price Target: $370 → $400
Current: $409.38
Upside: -2.29%
Aug 6, 2026
Maintained: Buy
Price Target: $30 → $25
Current: $25.07
Upside: -0.28%
Aug 6, 2026
Reiterated: Buy
Price Target: $145 → $130
Current: $99.39
Upside: +30.80%
Aug 5, 2026
Upgraded: Buy
Price Target: $160 → $310
Current: $288.50
Upside: +7.45%
Aug 4, 2026
Maintained: Hold
Price Target: $155 → $165
Current: $164.85
Upside: +0.09%
Aug 4, 2026
Maintained: Buy
Price Target: $230
Current: $218.22
Upside: +5.40%
Aug 4, 2026
Maintained: Hold
Price Target: $1,200 → $1,400
Current: $1,345.26
Upside: +4.07%
Aug 4, 2026
Maintained: Buy
Price Target: $195
Current: $161.41
Upside: +20.81%
Aug 4, 2026
Maintained: Hold
Price Target: $50 → $45
Current: $64.62
Upside: -30.36%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $12
Current: $14.97
Upside: -19.84%
Jul 29, 2026
Rated: Buy
Price Target: $165 → $175
Current: $167.60
Upside: +4.42%
Jul 29, 2026
Rated: Buy
Price Target: $255 → $285
Current: $267.77
Upside: +6.43%
Jul 28, 2026
Maintained: Buy
Price Target: $600 → $690
Current: $613.78
Upside: +12.42%
Jul 23, 2026
Maintained: Buy
Price Target: $245 → $220
Current: $207.66
Upside: +5.94%
Aug 9, 2024
Maintained: Hold
Price Target: $6 → $5
Current: $3.48
Upside: n/a